- Home
- JRS vs LENZ Comparison
JRS vs LENZ Comparison
Compare JRS & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JRS | LENZ |
|---|---|---|
| Founded | 2001 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 237.8M | 198.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | JRS | LENZ |
|---|---|---|
| Price | $8.59 | $5.90 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $44.00 |
| AVG Volume (30 Days) | 91.8K | ★ 701.8K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 8.87% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $19,088,000.00 |
| Revenue This Year | N/A | $50.42 |
| Revenue Next Year | N/A | $197.16 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.12 | $5.23 |
| 52 Week High | $8.75 | $50.19 |
Technical Indicators
Market Signals| Indicator | JRS | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 63.46 | 36.78 |
| Support Level | $7.96 | $5.23 |
| Resistance Level | N/A | $10.42 |
| Average True Range (ATR) | 0.18 | 0.42 |
| MACD | 0.03 | 0.05 |
| Stochastic Oscillator | 81.26 | 35.43 |
Price Performance
Historical ComparisonAbout JRS Nuveen Real Estate Income Fund of Beneficial Interest
Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund s investment objective is to provide total return through high current income and capital appreciation.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.